Karyopharm Therapeutics I... (KPTI)
NASDAQ: KPTI
· Real-Time Price · USD
6.48
0.13 (2.05%)
At close: Apr 30, 2025, 11:04 AM
Karyopharm Therapeutics Revenue
Karyopharm Therapeutics reported an annual revenue of $145.24M, reflecting a -0.55% growth. For the quarter ending December 31, 2024, Karyopharm Therapeutics generated $30.54M in revenue.
Revenue (ttm)
$145.24M
Revenue Growth
-0.55%
Price / Sales Ratio
8.51
Revenue / Employee
$520.56K
Employees
279
Market Cap
55.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 145.24M | -0.55% |
| Dec 31, 2023 | 146.03M | -7.03% |
| Dec 31, 2022 | 157.07M | -25.14% |
| Dec 31, 2021 | 209.82M | +94.12% |
| Dec 31, 2020 | 108.08M | n/a |